Walter Rosenthal
Prof. Dr. Walter Rosenthal
HRK President
University Medicine and Health Sciences
The President heads the Executive Board. He or she represents the HRK internally and externally, is responsible for the day-to-day business and convenes and chairs the meetings of the various decision-making bodies. The term of office is three years and holders may only be re-elected once.
| Year | Event | |
|---|---|---|
| Since 5/2023 | HRK President | |
| 12/2021-5/2023 | HRK Vice-President | |
| 10/2014-10/2023 | President of Friedrich Schiller University Jena (since 2020 2nd term) | |
| 2009-2014 | Chair of the Board and Scientific Director at the Max Delbrück Center for Molecular Medicine (MDC), Berlin-Buch | |
| 1996-2008 | Director of the Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) – Institute of the Leibniz Association, Berlin-Buch | |
| 1993-1996 | Professor of Pharmacology and Toxicology and Managing Director of the Rudolf Buchheim Institute of Pharmacology, Justus Liebig University Giessen | |
| 1991-1993 | Heisenberg Fellow and Visiting Professor in the Department of Cell Biology, Baylor College of Medicine, Houston, Texas (USA) | |
| 1990 | Habilitation in Pharmacology and Toxicology, Rudolf Virchow University Clinic, Freie Universität Berlin | |
| 1983 | Doctorate (summa cum laude) in Medicine, Justus Liebig University Giessen | |
| 1974-1981 | Medical studies at Justus Liebig University Giessen and the Royal Free Hospital, School of Medicine, London |
